The Journal of Emerging Drug Formulation Technologies (JEDFT) is an esteemed, peer-reviewed journal dedicated to publishing cutting-edge research and developments in the field of drug formulation. Founded with the aim of advancing pharmaceutical sciences, JEDFT serves as a vital resource for researchers, academicians, industry professionals, and policymakers involved in the discovery, design, and delivery of innovative drug formulations.

Our Vision

To be a global leader in the dissemination of knowledge and research in drug formulation technologies, driving innovation and fostering scientific excellence that enhances healthcare outcomes.

Our Mission

• To publish high-quality, original research articles, reviews, and case studies that contribute to the understanding and advancement of drug formulation technologies.
• To provide a platform for the exchange of ideas, knowledge, and expertise among scientists, researchers, and industry professionals worldwide.
• To promote interdisciplinary research and collaboration that bridges the gap between academic research and industrial applications.
• To support the development and implementation of innovative drug delivery systems that improve patient care and treatment efficacy.

Scope of the Journal

JEDFT focuses on a broad spectrum of topics within the pharmaceutical sciences, including:

• Novel Drug Delivery Systems: Innovations in the design and application of drug delivery platforms, including nanotechnology, controlled-release systems, and targeted delivery methods.
• Advanced Pharmaceutical Formulations: Research on the formulation of new drugs, including solid, liquid, and semi-solid dosage forms.
• Biopharmaceuticals and Biosimilars: Exploration of the formulation challenges and opportunities in biopharmaceuticals, including biologics and biosimilars.
• Regulatory Aspects: Discussions on the regulatory frameworks and guidelines governing drug formulation, including stability testing, quality control, and compliance.
• Stability Studies: Research on the stability, shelf-life, and degradation pathways of pharmaceutical products.
• In Vitro and In Vivo Evaluation: Studies on the evaluation of drug formulations through in vitro and in vivo methods, including bioavailability and pharmacokinetics.

Editorial Integrity and Peer Review

JEDFT adheres to the highest standards of editorial integrity and peer review. Our editorial board comprises leading experts in pharmaceutical sciences who ensure that every submission undergoes a rigorous review process to maintain the quality and relevance of the published content. We are committed to transparency, ethical publishing practices, and the continuous improvement of our journal.

Join Our Community

We invite researchers, scholars, and industry professionals to contribute to JEDFT by submitting their work, participating in peer review, or becoming part of our editorial team. Together, we can drive the future of drug formulation technologies and make a lasting impact on global healthcare.e.